AU2001280634A1 - Salt forms of an hiv protease inhibitor - Google Patents

Salt forms of an hiv protease inhibitor

Info

Publication number
AU2001280634A1
AU2001280634A1 AU2001280634A AU8063401A AU2001280634A1 AU 2001280634 A1 AU2001280634 A1 AU 2001280634A1 AU 2001280634 A AU2001280634 A AU 2001280634A AU 8063401 A AU8063401 A AU 8063401A AU 2001280634 A1 AU2001280634 A1 AU 2001280634A1
Authority
AU
Australia
Prior art keywords
protease inhibitor
salt forms
hiv protease
hiv
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280634A
Inventor
Stephen R. Anderson
Sridhar Desikan
Gregory D. Harris
Paul A. Meenan
Benjamin R. Stone
Pascal H. Toma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Pharma Co
Original Assignee
DuPont Merck Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Merck Pharmaceutical Co filed Critical DuPont Merck Pharmaceutical Co
Publication of AU2001280634A1 publication Critical patent/AU2001280634A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AU2001280634A 2000-07-19 2001-07-19 Salt forms of an hiv protease inhibitor Abandoned AU2001280634A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21979400P 2000-07-19 2000-07-19
US60/219,794 2000-07-29
PCT/US2001/022810 WO2002010124A2 (en) 2000-07-19 2001-07-19 Salt forms of an hiv protease inhibitor

Publications (1)

Publication Number Publication Date
AU2001280634A1 true AU2001280634A1 (en) 2002-02-13

Family

ID=22820809

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280634A Abandoned AU2001280634A1 (en) 2000-07-19 2001-07-19 Salt forms of an hiv protease inhibitor

Country Status (4)

Country Link
US (1) US20020022742A1 (en)
AR (1) AR029855A1 (en)
AU (1) AU2001280634A1 (en)
WO (1) WO2002010124A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6831164B2 (en) 2001-07-11 2004-12-14 Schering Aktiengesellschaft Process for the production of peracylated 1-0-glycosides
US8193227B2 (en) 2003-12-11 2012-06-05 Abbott Laboratories HIV protease inhibiting compounds
US20050131042A1 (en) * 2003-12-11 2005-06-16 Flentge Charles A. HIV protease inhibiting compounds
US20100082487A1 (en) * 2008-09-26 2010-04-01 Giftango Corporation Systems and methods for managing a virtual card based on geographical information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150556A (en) * 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
EP1140983A1 (en) * 1999-01-13 2001-10-10 Bristol-Myers Squibb Pharma Company Bis-amino acid sulfonamides containing n-terminally a fluoro-substituted benzyl group as hiv protease inhibitors

Also Published As

Publication number Publication date
WO2002010124A2 (en) 2002-02-07
WO2002010124A3 (en) 2003-05-01
US20020022742A1 (en) 2002-02-21
AR029855A1 (en) 2003-07-16

Similar Documents

Publication Publication Date Title
ZA9956B (en) Bisulfate salt of HIV protease inhibitor.
AU2001258771A1 (en) -secretase inhibitors
AP2052A (en) Pseudopolymorphic forms of HIV protease inhibitor
AU2001264770A1 (en) Prodrug of an ice inhibitor
AU2002305926A1 (en) Cysteine protease inhibitors
AU2002220241A1 (en) Parb inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2002360673A1 (en) Gp41 inhibitor
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2001280634A1 (en) Salt forms of an hiv protease inhibitor
AU2002316552A1 (en) Inhibitor of t cell activation
AU2002342682A1 (en) Protease inhibitors
AU2001251004A1 (en) Detection of viable agents
AU5089699A (en) Methods of making dihydropyrone hiv protease inhibitors
AU2002348465A1 (en) Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
AU2001282520A1 (en) Grk inhibitor
AU2001280636A1 (en) Crystalline and salt forms of an hiv protease inhibitor
PL370348A1 (en) Preparation of hiv protease inhibitors
AU2002305720A1 (en) Piperazine pentanamide hiv protease inhibitors
AU2002305868A1 (en) Inhibitors of reggamma
GB0028483D0 (en) Hydroxyethylamine HIV protease inhibitors
AU2003287325A1 (en) N-cycloalkylglycines as hiv protease inhibitors
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors